The suicide rate in Sweden decreased by The suicide rate in Sweden decreased by 25% during the 1990s. After analysing 25% during the 1990s. After analysing trends for the years 1978-96, I proposed trends for the years 1978-96, I proposed that the cause might be the concurrent inthat the cause might be the concurrent increased use of antidepressants, and data creased use of antidepressants, and data from Norway, Denmark, Finland, Hungary from Norway, Denmark, Finland, Hungary and the USA supported this hypothesis and the USA supported this hypothesis (Isacsson, 2000) . However, naturalistic stu- (Isacsson, 2000) . However, naturalistic studies do not allow definite conclusions, dies do not allow definite conclusions, which is why the importance of testing this which is why the importance of testing this hypothesis in other studies was stressed. hypothesis in other studies was stressed. Reseland Reseland et al et al (2006) recently published (2006) recently published an 'extended ' (1961-2001) analysis of suian 'extended ' (1961-2001) analysis of suicide and the use of antidepressants in the cide and the use of antidepressants in the four Nordic countries. They interpreted four Nordic countries. They interpreted two non-significant findings as 'contrasttwo non-significant findings as 'contrasting' with my data: in Sweden and Dening' with my data: in Sweden and Denmark, the decrease in suicide started mark, the decrease in suicide started before the introduction of selective serotobefore the introduction of selective serotonin reuptake inhibitors (SSRIs); the suicide nin reuptake inhibitors (SSRIs); the suicide rate in Norway later stabilised despite inrate in Norway later stabilised despite increased use of SSRIs. creased use of SSRIs.
However, the classification of deaths However, the classification of deaths was changed in 1969 with the introduction was changed in 1969 with the introduction of the category of uncertain cause of death of the category of uncertain cause of death in ICD-8. Statistics before 1969 are therein ICD-8. Statistics before 1969 are therefore not comparable with later data. fore not comparable with later data. Furthermore, forensic pathologists only Furthermore, forensic pathologists only gradually became accustomed to the new gradually became accustomed to the new classification and the proportions of suiclassification and the proportions of suicides to uncertain cases appear to have stacides to uncertain cases appear to have stabilised first in 1979 (Fig. 1) . Thus, the bilised first in 1979 (Fig. 1) . Thus, the decrease found by Reseland decrease found by Reseland et al et al in 'certain in 'certain suicides' in 1969-79 may be an artefact. A suicides' in 1969-79 may be an artefact. A better way of handling the uncertain cases better way of handling the uncertain cases might be to add them to the certain suicides might be to add them to the certain suicides (Linsley (Linsley et al et al, 2001 ). This would mean that , 2001). This would mean that the Swedish suicide rates increased in the Swedish suicide rates increased in 1969-79, decreased in 1979-89 and de-1969-79, decreased in 1979-89 Author's reply: Author's reply: Professor Isacsson raises Professor Isacsson raises an important issue concerning the interpretan important issue concerning the interpretation of national suicide data before and ation of national suicide data before and after the introduction (in 1969) of a new after the introduction (in 1969) of a new classification of deaths, 'injury undeterclassification of deaths, 'injury undetermined whether accidentally or purposely mined whether accidentally or purposely inflicted' (ICD-8). The points he raises do inflicted' (ICD-8). The points he raises do not, however, invalidate our conclusions. not, however, invalidate our conclusions.
The exclusion of pre-1969 or even preThe exclusion of pre-1969 or even pre-1979 (the period when the use of suicide 1979 (the period when the use of suicide and undetermined categories had stabilised and undetermined categories had stabilised in Sweden) data from our analyses does not in Sweden) data from our analyses does not alter our main finding that suicide reducalter our main finding that suicide reductions in three of the four Nordic countries tions in three of the four Nordic countries preceded the widespread use of SSRIs in preceded the widespread use of SSRIs in the early 1990s. With the exception of the early 1990s. With the exception of Sweden, suicide rates continued to increase, Sweden, suicide rates continued to increase, rather than decrease, in the period 1969-79 rather than decrease, in the period 1969-79 in the Nordic countries, indicating that the in the Nordic countries, indicating that the changed classification had a minor impact changed classification had a minor impact on apparent trends in these countries. on apparent trends in these countries.
There are well-recognised problems There are well-recognised problems with interpreting ecological data to infer with interpreting ecological data to infer causal effects. SSRIs, may 1979-89, prior to the use of SSRIs, may be a result of the increased use of tricyclic be a result of the increased use of tricyclic antidepressants. This is possible, but data antidepressants. This is possible, but data from Norway suggest that increased use from Norway suggest that increased use of non-SSRI antidepressants in the 1970s of non-SSRI antidepressants in the 1970s and 1980s was associated with increases and 1980s was associated with increases in suicide rates. in suicide rates.
Isacsson suggests that the stabilisation Isacsson suggests that the stabilisation in the decline in suicide rates is expected bein the decline in suicide rates is expected because not all people with depression consult cause not all people with depression consult doctors and conditions other than depresdoctors and conditions other than depression contribute to overall suicide numbers. sion contribute to overall suicide numbers. 7 9 7 9 B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY ( 2 0 0 7 ) , 1 9 0 , 7 9^8 2 ( 2 0 0 7 ) , 1 9 0 , We agree with this analysis. Nevertheless, We agree with this analysis. Nevertheless, the continued year-on-year rise in antidethe continued year-on-year rise in antidepressant use in the study period does indipressant use in the study period does indicate a wider population of individuals, cate a wider population of individuals, presumably some of whom are at risk of presumably some of whom are at risk of suicide, being treated by these drugs. suicide, being treated by these drugs. Our assessment of suicide and antideOur assessment of suicide and antidepressant prescribing in the Nordic countries pressant prescribing in the Nordic countries was more comprehensive than Isacsson's was more comprehensive than Isacsson's original analysis and in our view provides original analysis and in our view provides weaker evidence than that originally preweaker evidence than that originally presented (Isacsson, 2000) . Nevertheless the sented (Isacsson, 2000) . Nevertheless the most comprehensive assessment of the ecomost comprehensive assessment of the ecological data to date (Ludwig & Marcotte, logical (2006) reported that cognitive-behavioural therapy (CBT) was nitive-behavioural therapy (CBT) was more effective than brief dynamic therapy more effective than brief dynamic therapy (BDT) for the treatment of avoidant per-(BDT) for the treatment of avoidant personality disorder. However, the study has sonality disorder. However, the study has several methodological shortcomings. several methodological shortcomings.
In the BDT group it is not clear whether In the BDT group it is not clear whether and to what extent a manualised treatment and to what extent a manualised treatment was realised. The article includes non-specific was realised. The article includes non-specific references to several psychodynamic manuals references to several psychodynamic manuals and it is not clear what therapeutic proceand it is not clear what therapeutic procedures were actually carried out. Furthermore, dures were actually carried out. Furthermore, no disorder-specific treatment manual was no disorder-specific treatment manual was used. In contrast, in the CBT group the used. In contrast, in the CBT group the manual of Beck & Freeman (1990) for manual of Beck & Freeman (1990) for avoidant personality disorder was applied. avoidant personality disorder was applied. No data with regard to adherence and comNo data with regard to adherence and competence were reported and thus it is not petence were reported and thus it is not clear whether both treatments were carried clear whether both treatments were carried out with equal competence. out with equal competence.
Besides the presence or absence of the Besides the presence or absence of the diagnosis according to the Structural Clinidiagnosis according to the Structural Clinical Interview for DSM-IV Axis II Disorders cal Interview for DSM-IV Axis II Disorders (SCID-II) several self-report measures were (SCID-II) several self-report measures were applied as 'primary outcome measures'. applied as 'primary outcome measures'. However, the authors focus on a specific However, the authors focus on a specific measure that they regarded as primary. In measure that they regarded as primary. Beck & Freeman (1990) and hence the PDBQ is specifically (1990) and hence the PDBQ is specifically tailored to the effects of CBT. Possibly the tailored to the effects of CBT. Possibly the most convincing difference between CBT most convincing difference between CBT and BDT was found with regard to the and BDT was found with regard to the number of patients still fulfilling the number of patients still fulfilling the SCID-II criteria SCID-II criteria at follow-up (9 at follow-up (9 v. v. 36%). 36%). However, it is not However, it is not clear whether the 'indeclear whether the 'independent assessor' was masked to the treatpendent assessor' was masked to the treatment group. ment group.
In two outcome measures that refer In two outcome measures that refer more specifically to the features of avoidant more specifically to the features of avoidant personality disorder, the Social Phobia personality disorder, the Social Phobia Anxiety Inventory (SPAI) and the AvoidAnxiety Inventory (SPAI) and the Avoidance Scale, another measure developed by ance Scale, another measure developed by the authors (Emmelkamp, 1982) , both the authors (Emmelkamp, 1982) , both CBT and BDT achieved large and nearly CBT and BDT achieved large and nearly identical pre-/post-treatment effect sizes: identical pre-/post-treatment effect sizes: 0.92 0.92 v.
v. 0.82 (SPAI) and 1.88 0.82 (SPAI) and 1.88 v. v. 1.75 1.75 (Avoidance Scale). Emmelkamp (Avoidance Scale). Emmelkamp et al et al rereported that 'CBT was significantly superior ported that 'CBT was significantly superior on all primary outcome measures.' Howon all primary outcome measures.' However, for the difference between the CBT ever, for the difference between the CBT and BDT groups in SPAI score the and BDT groups in SPAI score the P P was was 0.09, which is not significant at the level 0.09, which is not significant at the level of of a a¼0.01 set by the authors. Furthermore, 0.01 set by the authors. Furthermore, at follow-up, there were no differences beat follow-up, there were no differences between CBT and BDT groups in SPAI and tween CBT and BDT groups in SPAI and Avoidance Scale scores. Differences were Avoidance Scale scores. Differences were only reported for the PDBQ and for two only reported for the PDBQ and for two scales that refer to other personality disorscales that refer to other personality disorders. For BDT, 'no significant difference ders. For BDT, 'no significant difference was found between BDT and control' but was found between BDT and control' but no data are reported. Compared with the no data are reported. Compared with the waiting list control, CBT was only superior waiting list control, CBT was only superior in two of six measures but the sample size in two of six measures but the sample size of the waiting list control was small of the waiting list control was small ( (n n¼15 15 v.
v. 26 for CBT and 28 for BDT 26 for CBT and 28 for BDT post-treatment). The fact that almost no post-treatment). The fact that almost no differences were found between the waitingdifferences were found between the waitinglist control and both BDT and CBT is (at least list control and both BDT and CBT is (at least in part) a result of the insufficient sample size. in part) a result of the insufficient sample size.
Furthermore, at least in some measures, the Furthermore, at least in some measures, the waiting-list group achieved medium or even waiting-list group achieved medium or even large effect sizes. large effect sizes.
The Author's reply: Author's reply: Our study was designed Our study was designed in close cooperation with full-time cliniin close cooperation with full-time clinicians and in both groups (CBT and BDT) cians and in both groups (CBT and BDT) application of manuals was highly flexible application of manuals was highly flexible to be representative of the respective therato be representative of the respective therapies as they are carried out in clinical pracpies as they are carried out in clinical practice and to enhance the external validity of tice and to enhance the external validity of the study. Sessions were audiotaped and the study. Sessions were audiotaped and scored using the Coding System of Therascored using the Coding System of Therapeutic Focus on Action and Insight (CFAI; peutic Focus on Action and Insight (CFAI; Samoilov Samoilov et al et al, 2000) by two independent , 2000) by two independent raters who were masked to the treatment raters who were masked to the treatment group (interrater reliability (Kendall's group (interrater reliability (Kendall's W W) ) ranged from 0.86 to 0.91). In general, reranged from 0.86 to 0.91). In general, results revealed that therapists adhered to sults revealed that therapists adhered to the respective therapies (Emmelkamp the respective therapies (Emmelkamp et et al al, 2004) .
, 2004).
To the best of our knowledge there are To the best of our knowledge there are no measures of 'psychodynamic origin' speno measures of 'psychodynamic origin' specifically related to avoidant personality cifically related to avoidant personality disorder and hence we used the PDBQ. disorder and hence we used the PDBQ. Furthermore, it was not feasible to keep Furthermore, it was not feasible to keep the independent assessors who completed the independent assessors who completed the SCID-II unaware of the treatment the SCID-II unaware of the treatment group in a number of instances. group in a number of instances.
Post-treatment CBT was significantly Post-treatment CBT was significantly superior to BDT on all 'primary' outcome superior to BDT on all 'primary' outcome measures. A significance level of measures. A significance level of a a¼0.1 set 0.1 set rather than 0.01 as claimed by Leichsenring rather than 0.01 as claimed by Leichsenring & Leibing. Even if we exclude the SPAI & Leibing. Even if we exclude the SPAI scores ( scores (P P¼0.09), this still leaves superior 0.09), this still leaves superior outcome for CBT on three out of four outoutcome for CBT on three out of four outcome variables. The lack of power to detect come variables. The lack of power to detect differences between the waiting-list control differences between the waiting-list control group and the active treatments is acknowlgroup and the active treatments is acknowledged as a limitation. edged as a limitation.
There are important differences beThere are important differences between our study and that of Svartberg tween our study and that of Svartberg et et al al (2004) . Svartberg (2004) . Svartberg et al et al included all types included all types of cluster C and self-defeating personality of cluster C and self-defeating personality disorders, rather than limiting their study disorders, rather than limiting their study to avoidant personality disorder. Twoto avoidant personality disorder. Twofifths of their sample did not fulfil criteria fifths of their sample did not fulfil criteria for avoidant personality disorder treatment for avoidant personality disorder treatment and treatment consisted of 40 rather than and treatment consisted of 40 rather than of 20 sessions. Furthermore, outcome with of 20 sessions. Furthermore, outcome with respect to personality disorders (sic) was respect to personality disorders (sic) was only assessed with the Millon Clinical only assessed with the Millon Clinical Multiaxial Inventory (Millon, 1994) , rather Multiaxial Inventory (Millon, 1994) , rather than with the gold standard SCID-II. Finalthan with the gold standard SCID-II. Finally, the lack of a control group in the study ly, the lack of a control group in the study of Svartberg of Svartberg et al et al renders the results diffirenders the results difficult to interpret. cult to interpret.
In contrast to most other psychotherapy In contrast to most other psychotherapy studies, we did our utmost to prevent an efstudies, we did our utmost to prevent an effect of investigator allegiance. The study fect of investigator allegiance. The study was designed in close cooperation with was designed in close cooperation with two psychodynamic therapists (G.F. and two psychodynamic therapists (G.F. and H.K.) and two cognitive-behavioural thera-H.K.) and two cognitive-behavioural therapists (A.B. and A.K.), who all fully participists (A.B. and A.K.), who all fully participated in the design of the study, selection of pated in the design of the study, selection of measures, treatment manuals (including demeasures, treatment manuals (including degree of flexibility) and therapists. gree of flexibility) and therapists. (2006) reported a clear relationship between the number of neuroleplationship between the number of neuroleptic drugs prescribed and mortality of people tic drugs prescribed and mortality of people with schizophrenia. The more important with schizophrenia. The more important causes of death were cardiovascular disease causes of death were cardiovascular disease and unspecified respiratory disease. Moreand unspecified respiratory disease. Moreover, the authors postulated that overover, the authors postulated that overlooked venous thrombosis or pulmonary looked venous thrombosis or pulmonary embolism accounted for some respiratory embolism accounted for some respiratory deaths. deaths.
Oomen Oomen et al et al (1995 Oomen et al et al ( ) documented in-(1995 documented increased vascular morbidity at 2-year folcreased vascular morbidity at 2-year follow-up in patients with anti-phospholipid low-up in patients with anti-phospholipid antibodies who were newly admitted for antibodies who were newly admitted for psychiatric treatment. These patients psychiatric treatment. These patients showed a range of cardiovascular accidents showed a range of cardiovascular accidents (arterial or venous thrombosis, pulmonary (arterial or venous thrombosis, pulmonary embolism and myocardial infarction). The embolism and myocardial infarction). The negative control group without anti-phosnegative control group without anti-phospholipid antibodies had no vascular compholipid antibodies had no vascular complications during follow-up. plications during follow-up.
Vascular events associated with such Vascular events associated with such autoantibodies range from superficial to autoantibodies range from superficial to life-threatening multiple organ thrombosis life-threatening multiple organ thrombosis developing over a short period ('catadeveloping over a short period ('catastrophic' anti-phospholipid syndrome). strophic' anti-phospholipid syndrome). Thrombosis in anti-phospholipid syndrome Thrombosis in anti-phospholipid syndrome appears to be a 'two-hit' phenomenon. appears to be a 'two-hit' phenomenon. Autoantibodies (the first 'hit') are continuAutoantibodies (the first 'hit') are continually present in the circulation, yet a local ally present in the circulation, yet a local trigger (the second 'hit') is required to intrigger (the second 'hit') is required to induce thrombus formation. Erkan & Lockduce thrombus formation. Erkan & Lockshin (2006) recently suggested the shin (2006) recently suggested the elimination of reversible thrombosis risk elimination of reversible thrombosis risk factors and heparin prophylaxis during factors and heparin prophylaxis during high-risk periods in people with persistent high-risk periods in people with persistent anti-phospholipid antibodies. Chengappa anti-phospholipid antibodies. Chengappa et al et al (1991) and Schwartz (1991) and Schwartz et al et al (1998 Schwartz et al et al ( ) de-(1998 demonstrated a high prevalence of anti-phosmonstrated a high prevalence of anti-phospholipid antibodies (about 30%) in pholipid antibodies (about 30%) in patients. A prospective study is ongoing in patients. A prospective study is ongoing in our departments to confirm the prevalence our departments to confirm the prevalence of anti-phospholipid antibodies with a first of anti-phospholipid antibodies with a first episode of acute psychosis before and after episode of acute psychosis before and after neuroleptic treatment. If historical data are neuroleptic treatment. If historical data are confirmed, more attention should be paid confirmed, more attention should be paid to the fact that up to one-third of patients to the fact that up to one-third of patients presenting with psychosis have anti-phospresenting with psychosis have anti-phospholipid antibodies and are at risk of cardipholipid antibodies and are at risk of cardiovascular or respiratory morbidity/ ovascular or respiratory morbidity/ mortality when neuroleptic treatment or mortality when neuroleptic treatment or physical restraint are used. physical restraint are used. 
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